Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Yarnell

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 24, 2010
C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME studyJean-Philippe Empana, Xavier Jouven, Florence Canouï-Poitrine, et al.
Circulation|May 26, 2010
Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker projectStefan Blankenberg, Tanja Zeller, Olli Saarela, et al.
Stroke|June 13, 2009
Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM ProjectKjell Asplund, Juha Karvanen, Simona Giampaoli, et al.
European Heart Journal|May 14, 2016
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortiumStefan Blankenberg, Veikko Salomaa, Nataliya Makarova, et al.
European Heart Journal|April 28, 2017
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortiumChristoph Waldeyer, Nataliya Makarova, Tanja Zeller, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 24, 2010
C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME studyJean-Philippe Empana, Xavier Jouven, Florence Canouï-Poitrine, et al.
Circulation|May 26, 2010
Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker projectStefan Blankenberg, Tanja Zeller, Olli Saarela, et al.
Stroke|June 13, 2009
Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM ProjectKjell Asplund, Juha Karvanen, Simona Giampaoli, et al.
European Heart Journal|May 14, 2016
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortiumStefan Blankenberg, Veikko Salomaa, Nataliya Makarova, et al.
European Heart Journal|April 28, 2017
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortiumChristoph Waldeyer, Nataliya Makarova, Tanja Zeller, et al.
Pageof 4